{"schema_version":"secwatch.filing_event.v1","accession":"0001564590-22-002820","form_type":"8-K","ticker":"CHD","cik":"0000313927","company_name":"CHURCH & DWIGHT CO INC /DE/","filed_at":"2022-01-28T23:59:59+00:00","discovered_at":"2026-05-14T18:04:09.210061+00:00","generated_at":"2026-06-27T14:24:39.172617+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Church & Dwight Q4 EPS beats outlook; raises dividend 4%; guides 2022 EPS +4-8%","bullets":["Q4 net sales $1,368.7M (+5.7% YoY); organic sales +4.3% (outlook 2%); reported EPS $0.64 beats $0.58 outlook.","Full-year net sales $5,190.1M (+6%); adj. EPS $3.02 (+6.7%); cash from ops $993.8M.","Board declares 4% dividend increase to $0.2625/quarter; payable March 1 to record Feb 15.","Closed THERABREATH acquisition in Dec; projected 2022 sales $100M; fits oral care portfolio.","2022 guidance: EPS $3.14-$3.26 (+4-8%); sales growth 5-8% reported, 3-6% organic; sees $155M cost inflation."],"urls":{"canonical":"https://secwatch.observer/filing/0001564590-22-002820","json":"https://secwatch.observer/filing/0001564590-22-002820.json","markdown":"https://secwatch.observer/filing/0001564590-22-002820.md","text":"https://secwatch.observer/filing/0001564590-22-002820.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/313927/000156459022002820/0001564590-22-002820-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/313927/000156459022002820/chd-8k_20220128.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T14:24:39.172617+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}